New Jersey A 4426: Requires bio-analytical or clinical laboratory conducting hepatitis C screening test to draw and store blood for confirmation test.

Status: Introduced in the Assembly, Referred to Assembly Health Committee (as of 2022-06-29)

State: New Jersey · Session: 220 · Bill: A 4426

Subjects: DISEASE, HEALTH FAC

Sponsors: Conaway, Herb, Mukherji, Raj

View New Jersey A 4426 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.